Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00139269
What this trial is testing

Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Advanced Squamous Cell CarcinomaSquamous Cell Carcinoma of Head and NeckSSCHN
Dana-Farber Cancer Institute 38
Early research (Phase 1)Study completedNCT03565445
What this trial is testing

ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 190
Large-scale testing (Phase 3)Ended earlyNCT03452137
What this trial is testing

Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Hoffmann-La Roche 406
Testing effectiveness (Phase 2)Study completedNCT00459043
What this trial is testing

Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT01312350
What this trial is testing

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

Who this might be right for
Hypopharyngeal Cancer
Samsung Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT02753140
What this trial is testing

Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 60
Early research (Phase 1)WithdrawnNCT00627835
What this trial is testing

Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Who this might be right for
Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
British Columbia Cancer Agency
Testing effectiveness (Phase 2)Ended earlyNCT01111058
What this trial is testing

Everolimus Versus Placebo in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Chicago 52
Testing effectiveness (Phase 2)Study completedNCT00387127
What this trial is testing

Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer

Who this might be right for
Neoplasms, Head and Neck
GlaxoSmithKline 67
Large-scale testing (Phase 3)Active Not RecruitingNCT02999087
What this trial is testing

Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH)

Who this might be right for
HNSCC
Groupe Oncologie Radiotherapie Tete et Cou 707
Large-scale testing (Phase 3)Study completedNCT03349710
What this trial is testing

Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Bristol-Myers Squibb 74
Testing effectiveness (Phase 2)Ended earlyNCT01245985
What this trial is testing

TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors

Who this might be right for
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal Cancer
Heidelberg University 8
Testing effectiveness (Phase 2)Study completedNCT00865098
What this trial is testing

Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Who this might be right for
Carcinoma of the Head and Neck
Merck KGaA, Darmstadt, Germany 27
Testing effectiveness (Phase 2)Study completedNCT02609503
What this trial is testing

Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin

Who this might be right for
Head and Neck Cancer
UNC Lineberger Comprehensive Cancer Center 29
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Testing effectiveness (Phase 2)Study completedNCT02001623
What this trial is testing

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Who this might be right for
Ovary CancerCervix CancerEndometrium Cancer+5 more
Seagen Inc. 195
Testing effectiveness (Phase 2)Study completedNCT00095927
What this trial is testing

Randomized Amifostine For SCCHN

Who this might be right for
Chemotherapeutic Agent ToxicityHead and Neck CancerMucositis+2 more
Dana-Farber Cancer Institute 58
Testing effectiveness (Phase 2)Ended earlyNCT04052204
What this trial is testing

Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Metastatic Castration Resistant Prostate Cancer (mCRPC)
Pfizer 3
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Testing effectiveness (Phase 2)Ended earlyNCT04034225
What this trial is testing

Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Sensei Biotherapeutics, Inc. 25
Next Page